Analysis of Patients Treated for Chronic Granulomatous Disease Since January 1, 1995 | MicrobiomeTrials← Back to trialsNCT02116764
Analysis of Patients Treated for Chronic Granulomatous Disease Since January 1, 1995
CompletedOBSERVATIONAL
Trial Details
Start: 2014-06-11Est. Completion: 2022-06-02
Enrollment target: 137 participants Locations- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Other microbiome trials you might be interested in
Chronic Granulomatous Disease (CGD)
Background:
X-Linked Chronic Granulomatous Disease (X-CGD) is caused by a gene mutation that makes the immune system to…
Bethesda, United StatesCompleted Sep 1, 2028
Chronic Granulomatous Disease (CGD)X-Linked Chronic Granulomatous Disease
Background:
Chronic granulomatous disease (CGD) is a rare immune disorder caused by a mutation in the CYBB gene. People…
Bethesda, United StatesEst. completion Dec 31, 2032